Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, July 29, 2014
 
Register | Sign in
Home Page>Products
  Product News
GE Healthcare Launches Cytell™ Cell Imaging System
Wednesday, June 25, 2014
Streamlines data acquisition, analysis and visualization.

New XFp Analyzer from Seahorse Bioscience
Wednesday, June 25, 2014
Makes measuring metabolism affordable for every lab.

VolitionRx Sells First NuQ® Research Use Only Kits to Active Motif
Tuesday, June 24, 2014
First revenues from VolitionRx Nucleosomics technology.

Consistent & Efficient Purification of NGS Library Reactions
Tuesday, June 24, 2014
MagSi-NGSPREP offers an efficient solution for DNA clean-up and size selection.

Summer 2014 Program of Lyophilization Webinars
Tuesday, June 24, 2014
LyoLearn program devoted to lyophilization, freeze-drying and related topics.

Sometimes it Just Has to Be Glass
Tuesday, June 24, 2014
With the cost-efficient filled and unfilled SPE glass columns as well as matching accessories LCTech simplifies the daily routine in laboratories.

Molecular Devices to attend 9th FENS Forum of Neuroscience 2014
Tuesday, June 24, 2014
Company will be showcasing its range of Axon Instruments at FENS 2014 (Hall 4, Booth 146) in Milan from 5 July 2014.

Tecan Unveils Fluent™ Laboratory Automation Solutions
Tuesday, June 24, 2014
Tecan has introduced the Fluent™ laboratory automation solution, the latest addition to its world-class laboratory automation portfolio.

Thermo Fisher Showcases New Product Innovations and Best Practices to Optimize Stem Cell Discoveries at ISSCR 2014
Monday, June 23, 2014
Enabling engineering, expansion, differentiation, characterization, cryopreservation and ultra-cold chain to drive drug discovery applications.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 10360
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv